Daniel Scheurich, M.D.
, and Keith Woeltje, M.D., Ph.D.
Dr. Scheurich is clinical fellow, Department of Medicine, and Dr. Woeltje is Associate Professor, Infectious Diseases, Washington University School of Medicine, St. Louis, MO.
Within the past 12 months, Drs. Scheurich and Woeltje report no commercial conflicts of interest.
Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.
Estimated time to complete:
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Albert Einstein College of Medicine is accredited
by the Accreditation Council for Continuing
Medical Education to provide continuing medical
education for physicians.
Upon completion of this Cyberounds®
, you should be able to:
- Discuss a shift in etiologic agents in skin and soft tissue infections.
- Enumerate risk factors for carriage and development of infections caused by CA-MRSA.
- Describe surgical and pharmacologic methods of treatment of skin and skin structure infections caused by CA-MRSA.
- List and evaluate methods of eradication of CA-MRSA carriage.